156 related articles for article (PubMed ID: 22153801)
1. Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Zhao T; Zhang H; Zhao T; Zhang X; Lu J; Yin T; Liang Q; Wang Y; Luo G; Lan H; Li P
J Pharm Biomed Anal; 2012 Feb; 60():32-43. PubMed ID: 22153801
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic and lipidomic study of the protective effect of Chaihuang-Yishen formula on rats with diabetic nephropathy.
Zhao T; Zhang H; Zhang X; Zhao T; Lan HY; Liang Q; Luo G; Li P
J Ethnopharmacol; 2015 May; 166():31-41. PubMed ID: 25698246
[TBL] [Abstract][Full Text] [Related]
3. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
[TBL] [Abstract][Full Text] [Related]
5. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats.
Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT
Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407
[TBL] [Abstract][Full Text] [Related]
6. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
[TBL] [Abstract][Full Text] [Related]
7. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin.
Liu G; Han F; Yang Y; Xie Y; Jiang H; Mao Y; Wang H; Wang M; Chen R; Yang J; Chen J
Nephrol Dial Transplant; 2011 May; 26(5):1493-502. PubMed ID: 20961887
[TBL] [Abstract][Full Text] [Related]
11. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats.
Sato S; Yamate J; Hori Y; Hatai A; Nozawa M; Sagai M
J Nutr Biochem; 2005 Sep; 16(9):547-53. PubMed ID: 16115543
[TBL] [Abstract][Full Text] [Related]
13. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
[TBL] [Abstract][Full Text] [Related]
15. Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-kappaB and IkappaB in renal cortex of streptozotoxin-induced diabetic rats.
Zhang YW; Wu CY; Cheng JT
J Ethnopharmacol; 2007 Dec; 114(3):387-92. PubMed ID: 17900838
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.
Chen LL; Zhang JY; Wang BP
Vascul Pharmacol; 2006 May; 44(5):309-15. PubMed ID: 16624630
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
Nakagawa T; Yokozawa T; Yamabe N; Rhyn DY; Goto H; Shimada Y; Shibahara N
J Pharm Pharmacol; 2005 Sep; 57(9):1205-12. PubMed ID: 16105242
[TBL] [Abstract][Full Text] [Related]
18. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
Zuo Y; Gu Y; Ma J; Lin S
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):239-43. PubMed ID: 11953170
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.
Baylis C; Atzpodien EA; Freshour G; Engels K
J Pharmacol Exp Ther; 2003 Dec; 307(3):854-60. PubMed ID: 14560039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
